Group 1 - Guangkang Biotech (300804.SZ) released its semi-annual report for 2025 on August 22, 2025, indicating that as of August 21, 2025, a total of 8 institutional investors disclosed holdings in Guangkang Biotech A-shares, with a total holding of 10.2497 million shares, accounting for 13.85% of the total share capital [1] - The institutional investors include several firms such as Yingde Zhongxing Investment Management Co., Ltd., Shenzhen Qianhai Ruihong Kaiyin Asset Management Co., Ltd., and Morgan Stanley & Co. International PLC, among others [1] - Compared to the previous quarter, the total proportion of institutional holdings decreased by 5.09 percentage points [1] Group 2 - In the public fund sector, one public fund, CITIC Prudential Multi-Strategy Mixed (LOF) A, was not disclosed in this period compared to the previous quarter [2] - Regarding foreign investment attitudes, one new foreign institution disclosed in this period is Morgan Stanley & Co. International PLC [2]